DNA samples from POI patients and controls were extracted using the G-DEX blood extraction kit (iNtRON Biotechnology Inc., Seongnam, Korea). miRNA SNPs were selected using the human genome SNP database (dbSNP; http://www.ncbi.nlm.nih.gov/snp): miR-938G>A (rs12416605). Samples were genotyped by PCR-restriction fragment length polymorphism (PCR-RFLP) analysis with the following primers and PCR conditions. miR-938G>A polymorphism was detected using primers (forward) 5′-T GGT GCA CTG GGT TCA CCT TTA AGC G-3′ and (reverse) 5′-GTA ATA CCT CTG AGC CTT TGG GGC C-3′ under conditions of initial denaturation at 95 °C for 5 min; 35 cycles of denaturation at 95 °C for 30 s, annealing at 64 °C for 30 s, and extension at 72 °C for 30 s; and final extension at 72 °C for 5 min. PCR products were digested using the restriction enzyme HhaI (New England BioLabs, Ipswich, MA, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.